#ranbaxy laboratories

मलविंदर-शिविंदर के खिलाफ दाइची सैंक्यो की याचिका पर सुप्रीम कोर्ट आज फैसला सुना सकता है

[ad_1]

नई दिल्ली.रैनबैक्सी के पूर्व प्रमोटर मलविंदर सिंह (45) और शिविंदर सिंह (43) के खिलाफ जापानी दवा कंपनी दाइची सैंक्यो की याचिका पर सुप्रीम कोर्ट आज फैसला सुना सकता है। ये मामला 3,500 करोड़ रुपए के आर्बिट्रेशन अवॉर्ड का है। दाइची का कहना है कि मलविंदर-शिविंदर ने इस रकम का भुगतान नहीं किया। दाइची ने इस साल मार्च में सुप्रीम कोर्ट में दोनों भाइयों के खिलाफ अवमानना याचिका भी दायर की थी। उसका…

Former promoters of pharma major Ranbaxy, hospital chain Fortis and financial services firm Religare - Malvinder Mohan Singh and his younger brother Shivinder Mohan Singh - were arrested by the Economic Offences Wing (EoW) of Delhi Police after some high octane drama for allegedly causing wrongful loss worth Rs 2,397 crore to Religare Finvest Ltd. Shivinder was nabbed in the afternoon, while his elder brother Malvinder was arrested in Ludhiana (Punjab) late night after a brief search.

Along with the Singh brothers, the police also arrested former Religare Finvest MD Kavi Arora, and former Religare Group CFO Anil Saxena along with former Religare MD Sunil Godhwani.

A statement issued by the EOW said, "The alleged persons having absolute control on Religare Enterprises Limited (REL) and its subsidiaries put Religare Finvest Limited (RFL) in poor financial condition by way of distributing the loans to the companies having no financial standing and controlled by the alleged persons. These companies wilfully defaulted on repayments, causing a loss to RFL to the tune of Rs 2,397 crore." Read More

Sun Pharmaceuticals of India to Buy Ranbaxy, a Smaller Rival

Read More

General Motors India Pvt. Ltd vs. DCIT (ITAT Ahmedabad)

Transfer Pricing: Foreign associated enterprise can be taken as ‘Tested Party’

The assessee bought CKD Kits from General Motor Daewoo Auto & Technology (GMDAT), a foreign associated enterprise. The…